Mechanical disruption of the blood-brain barrier following experimental concussion by Johnson, Victoria E. et al.
 
 
 
 
 
Johnson, V. E., Weber, M. T., Xiao, R., Cullen, D. K., Meaney, D. F., 
Stewart, W. and Smith, D. H. (2018) Mechanical disruption of the blood-
brain barrier following experimental concussion. Acta Neuropathologica, 
135(5), pp. 711-726. (doi:10.1007/s00401-018-1824-0) 
 
This is the author’s final accepted version. 
 
There may be differences between this version and the published version. 
You are advised to consult the publisher’s version if you wish to cite from 
it. 
 
 
 
 
http://eprints.gla.ac.uk/157501/ 
     
 
 
 
 
 
 
Deposited on:  19 February 2018 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Page 1 of 24 
 
Mechanical Disruption of the Blood-Brain Barrier Following Experimental 
Concussion 
 
Victoria E. Johnson1, Maura T. Weber1, Rui Xiao2, D. Kacy Cullen1,3,4, David F. Meaney3, William Stewart5,6, 
Douglas H. Smith1* 
 
1. Department of Neurosurgery, Penn Center for Brain Injury and Repair, Perelman School of Medicine, University 
of Pennsylvania, Philadelphia, PA 19104, USA. 2. The Department of Biostatistics, Epidemiology and Informatics, 
University of Pennsylvania, Philadelphia, PA 19104.  3. Department of Bioengineering, University of Pennsylvania, 
Philadelphia, PA 19104 4. Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104, USA 5. 
Department of Neuropathology, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK. 6. Institute of 
Neuroscience and Psychology, University of Glasgow, Glasgow, G12 8QQ, UK. 
 
Corresponding Author: 
Douglas H. Smith, M.D. 
The Robert F. Groff Professor of Neurosurgery 
Department of Neurosurgery 
Director of Penn Center for Brain Injury and Repair 
105 Hayden Hall 
3320 Smith Walk 
University of Pennsylvania 
Philadelphia, PA19104 
USA 
Email. smithdou@pennmedicine.upenn.edu 
Tel. 215-898-0881 
 
 
ACKNOWLEDGEMENTS: 
The authors thank Kathryn Wofford for assistant with kinematic measurements. Research reported in this 
publication was supported by the Department of Defense grant W81XWH-13-1-0052, and the National Institute of 
Neurological Disorders and Stroke of the National Institutes of Health under award numbers R01NS092398, 
R01NS094003 and R01NS038104, and the Department of Veterans Affairs under Merit Review number 
I01RX001097. Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent 
the official views of the Department of Defense, National Institutes of Health, or Department of Veterans Affairs.   
Page 2 of 24 
ABSTRACT 
Although concussion is now recognized as a major health issue, its non-lethal nature has limited characterization of 
the underlying pathophysiology.  In particular, potential neuropathological changes have typically been inferred 
from non-invasive techniques or post-mortem examinations of severe traumatic brain injury (TBI).  Here, we used 
a swine model of head rotational acceleration based on human concussion to examine blood brain barrier (BBB) 
integrity after injury in association with diffuse axonal injury and glial responses.  We then determined the potential 
clinical relevance of the swine concussion findings through comparisons with pathological changes in human severe 
TBI, where post-mortem examinations are possible.  At 6-72h post-injury in swine, we observed multifocal 
disruption of the BBB, demonstrated by extravasation of serum proteins, fibrinogen (FBG) and Immunoglobulin-
G, in the absence of hemorrhage or other focal pathology. BBB disruption was observed in a stereotyped distribution 
consistent with biomechanical insult. Specifically, extravasated serum proteins were frequently observed at 
interfaces between regions of tissue with differing material properties, including the gray-white boundary, 
periventricular and subpial regions. In addition, there was substantial overlap of BBB disruption with regions of 
axonal pathology in the white matter. Acute perivascular cellular uptake of blood-borne proteins was observed to 
be prominent in astrocytes (GFAP-positive) and neurons (MAP-2-positive), but not microglia (IBA1-positive).  
Parallel examination of human severe TBI revealed similar patterns of serum extravasation and glial uptake of 
serum proteins, but to a much greater extent than in the swine model, attributed to the higher injury severity.  These 
data suggest that BBB disruption represents a new and important pathological feature of concussion.  
 
Keywords: Mild traumatic brain injury, concussion, blood brain barrier, fibrinogen, gliosis, biomechanics 
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INTRODUCTION 
 Concussion is now recognized as a major health issue, with many millions of cases reported worldwide 
each year [11, 18, 61].  Indeed, although alternatively referred to as mild traumatic brain injury (mTBI), for many 
there is nothing ‘mild’ about concussion, with approximately 15% of patients suffering persisting neurocognitive 
dysfunction [68, 70]. Moreover, an increasing number of reports link exposure to repetitive concussions with 
progressive neurodegeneration, including ‘chronic traumatic encephalopathy’ (CTE) [33, 57, 83].  
 Despite growing public alarm regarding the aftermath of concussion, there remains no consensus on the 
underlying pathophysiology of the injury.  In part, this is due to the limited availability of human post-mortem brain 
tissue for examination from this typically non-lethal injury. As such, concussion remains in part defined by an 
absence of the overt brain pathologies characteristic of higher levels of TBI, including, hematoma, contusion or 
marked brain swelling [51].  However, emerging experimental and clinical data indicates that concussion may share 
one of the most consistently observed pathologies of moderate and severe TBI, diffuse axonal injury (DAI).    
Across all injury severities, DAI is thought to stem from the viscoelastic nature of the brain under dynamic 
mechanical loading during head rotational acceleration [3, 26, 36, 37, 43, 58, 84, 86, 87].  Potentially due to their 
highly-structured organization in tracts and unique anatomic architecture, axons appear especially vulnerable to 
rapid brain tissue deformation during TBI. This has been demonstrated in a swine model of concussion that employs 
head rotational acceleration parameters scaled to human concussion [17, 44].  Neuropathological analysis of the 
injured swine brains identified selective multifocal regions of axonal pathology throughout the white matter very 
similar in appearance to characteristic DAI observed at autopsy after severe TBI in humans [44]. In addition, a 
growing number of reports using advanced neuroimaging and fluid biomarker analyses lend further support for DAI 
as a key pathological substrate of concussion in both humans and animal models [12, 55, 59, 76, 81, 94, 95].   
Intriguingly, emerging evidence suggests that other brain structures also suffer mechanical injury during 
concussion, which like DAI, typically are invisible to conventional non-invasive examination. In particular, while 
by definition there is no focal hemorrhage in concussion, techniques such as dynamic contrast enhanced (DCE) 
MRI have demonstrated contrast accumulation in the brains of football players [93], suggesting there is subtle 
disruption of the cerebral vasculature affecting the integrity of the blood-brain barrier (BBB). In addition, in 
previous preclinical studies, BBB dysfunction has been observed in the absence of other significant 
neuropathologies following an open-skull, direct impact model of TBI in cats [66, 67]. In these studies, BBB 
permeability was demonstrated to occur via multiple routes including increased transcytosis as well as hypertension-
induced endothelial breakdown. Furthermore, autopsy studies in humans have demonstrated acute and long-lasting 
disruption of BBB integrity as a common neuropathological finding after just a single moderate or severe TBI [34]. 
However, the specific contribution of isolated mechanical forces on the BBB, including rotational forces common 
to concussion, has yet to be explored directly. 
 Here, we evaluated potential BBB disruption following injury in the swine head rotational acceleration 
model of concussion.  We found acute and marked BBB leakage at levels of injury insufficient to cause hemorrhage. 
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Detailed neuropathological examination revealed that BBB permeability occurred in a pattern and distribution 
consistent with a biomechanically induced pathology and was associated with an acute astroglial response.  Parallel 
studies of human cases of moderate and severe TBI confirmed neuropathological features similar to those found in 
the swine concussion model, though with evidence of more extensive BBB disruption, consistent with previous 
observations.  Together, these data indicate that, in addition to DAI, BBB dysfunction may also be an important 
pathology of concussion. 
 
MATERIALS AND METHODS 
Experimental Design 
We hypothesized that dynamic forces caused by rapid head rotational acceleration-deceleration in adult swine will 
induce acute extravasation of blood-borne proteins into the brain parenchyma that are detectable via 
immunohistochemistry (IHC). In a controlled laboratory experiment, 6-month old (adult) Hanford miniature swine 
underwent the rotational acceleration model of TBI under general anesthesia and survived for 6 hours (n=3), 48 
hours (n=2) and 72 hours (n=4), and were compared with shams (n=3). Based on previous data [44] the proposed 
number of animals was expected to provide significant power, specifically where the neuropathological outcome 
was anticipated to be absent in sham animals. All histological experiments, analyses and quantification were 
performed blind to the injury status of the animal. 
 
Rotational Acceleration Model of Concussion 
All animal experiments were conducted in accordance with protocols approved by The University of 
Pennsylvania Institutional Animal Care and Use Committee and in accordance with the NIH Guide for the Care and 
Use of Laboratory Animals.  
6-month-old female Hanford miniature swine were subjected to an established concussion model that 
induces injury via forces caused by rotational acceleration / deceleration due to pure impulsive centroidal head 
rotation [17, 44, 58, 71, 82, 85]. For TBI in humans, the size of the brain is critical as significant mass effects 
between regions of tissue can create high strains during dynamic brain deformation during rapid accelerations [36, 
37, 54].  Accordingly, injury parameters were scaled up relative to brain mass to create the mechanical loading of 
brain tissue relevant to that which occurs in human TBI [36, 37, 54, 58, 89]. Notably, in this model, there is an 
absence of any head impact or forces arising from linear acceleration / deceleration. 
Following induction of anesthesia using 0.4mg/kg midazolam IM and 5% inhaled isoflurane, animals were 
intubated and anesthesia maintained via 2.5% inhaled isoflurane. The HYGE pneumatic actuator device was used 
to induce rapid head rotation. Specifically, the HYGE actuator generates linear motion via the triggered release of 
pressurized nitrogen. This linear motion is then converted to angular motion via custom-designed linkage 
assemblies to induce rotation over 20 msec. Rotational kinematics were recorded using angular velocity transducers 
(Applied Technology Associates) mounted to the linkage sidearm coupled to a National Instruments data acquisition 
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system running custom LabView software (10 kHz sampling rate). In this fashion, we produced pure impulsive 
centroidal head rotation of up to 110o in the coronal plane with peak angular velocity of 225-250rad/sec.  Animals 
were recovered from anesthesia and returned to the housing facility. While the procedure is non-surgical, 
preemptive analgesia was provided post-injury in the form of 0.1-3mg of Buprenex (slow release preparation) SQ 
and acetaminophen 50mg/kg PR. Sham animals were also euthanized 72-hours after being subjected to identical 
procedures absent head rotation. 
At the study endpoint, all animals were deeply anesthetized and transcardially perfused using chilled 
heparinized saline (2L) followed by 10% neutral buffered formalin (NBF) (8L). Perfusions were performed at 
standardized pressures calibrated for the provision of adequate fixation and the absence of any structural damage 
to the vasculature that would permit artefactual extravasation of serum proteins. This was verified histologically 
(described below) and fixation was sufficient to permit quality tissue morphology and immunoreactivity. Brains 
were subsequently post-fixed for 7 days in 10% NBF, sectioned into 5mm blocks in the coronal plane and 
processed to paraffin using standard techniques. 
 
Human Post-Mortem Acute Severe TBI Cohort: Demographic and Clinical Data 
Since uncomplicated concussion is typically non-lethal, scarce cases come to autopsy examination.  
Therefore, post-mortem brain tissue from patients who died following single severe TBI was examined to determine 
if there were shared features in the distribution of serum protein extravasation and the cellular response to BBB 
breakdown between human autopsy material and our swine injury model across injury severities.  All tissue was 
obtained from the Glasgow TBI Archive, Department of Neuropathology, Queen Elizabeth University Hospital, 
Glasgow, UK.  Tissue was acquired at routine diagnostic autopsy and approval for use was granted by the NHS 
Greater Glasgow and Clyde Bio-repository Governance Committee.  
 TBI cases were selected to include patients with survival times ranging from 6 -72 hours following acute 
severe TBI (n=12). Detailed reports from the diagnostic autopsy and/or forensic reports were available for all cases 
and indicated a history of a single severe TBI, supported by autopsy findings. TBI cases were compared to material 
from age/sex-matched controls (n=7) acquired at routine diagnostic post-mortem at the same institution. Controls 
had no documented history of TBI. Full clinical and demographic information, including age, sex and cause of 
death, is provided for all groups in Table 1. 
 
Human Brain Tissue Preparation 
 For all examinations, the intact brain was immersed in 10% formol saline at autopsy and fixed for at least 
3-weeks prior to dissection. Sampling using a standardized protocol and paraffin embedding was performed as 
described previously [31]. Analyses were performed using hemi-coronal sections of the parasagittal cortex at the 
level of the mid-thalamus to include the cingulate gyrus, corpus callosum and superior frontal gyrus. This region 
was selected given its midline location and known susceptibility to injury [1, 2, 42, 43, 49]. 
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Single Immmunohistochemcial Labeling  
Human and swine tissue was examined for extravasation of the serum protein fibrinogen (FBG) and axonal 
pathology using IHC. Following deparaffinization and rehydration, human and swine tissue sections were immersed 
in aqueous hydrogen peroxide (15 minutes) to quench endogenous peroxidase activity. Antigen retrieval was 
performed in a microwave pressure-cooker with immersion in preheated Tris EDTA buffer. Subsequent blocking 
was achieved using 1% normal horse serum (Vector Labs, Burlingame, CA) in Optimax buffer (BioGenex, San 
Ramon, CA) for 30-minutes. Incubation with the primary antibodies was performed overnight at 4oC. Specifically, 
to identify axonal pathology in human and swine tissue, sections were labeled with an antibody reactive for the N-
terminal amino acids 66-81 of the amyloid precursor protein (APP) (Millipore, Billerica, MA) at 1:80k permitting 
visualization of APP accumulating within transport-interrupted axonal bulbs or swollen and tortuous varicosities 
along the length of damaged axons. In addition, adjacent sections were incubated with antibodies specific for the 
serum protein FBG including rabbit polyclonal antibodies targeting the full-length swine FBG at 1:5k (Abcam, 
Cambridge, MA) and human FBG at 1:17.5K (Dako, Carpinteria, CA). FBG does not normally accumulate in the 
brain parenchyma under physiologic conditions. After rinsing, sections were incubated with the appropriate 
biotinylated secondary antibody for 30-minutes (Vector Labs, Burlingame, CA), followed by avidin-biotin complex 
(Vectastain Universal Elite kit, Vector Labs, Burlingame, CA). Finally, visualization was achieved using 3,3’-
diaminobenzidine (DAB) (Vector Labs, Burlingame, CA) and counterstaining with haematoxylin performed. 
Positive control tissue for APP IHC included sections of swine tissue with previously established DAI. 
Positive control tissue for FBG IHC included a section of swine brain tissue with contusional injury and thus overt 
BBB disruption. Omission of primary antibodies was performed on the same material to control for non-specific 
binding.  
 
Multiple Antigen Labeling 
Immunoenzymatic Double Labeling: Sections were examined to directly compare the pattern and distribution of 
FBG extravasation with that of axonal pathology in swine. Specifically, APP staining was first performed using 
DAB visualization as above. The same sections were subsequently incubated with rabbit anti-FBG antibody 
(1:3.5K) for 20h at 4oC.  Detection was achieved via the ImmPRESS™-AP anti-rabbit IgG (alkaline phosphatase) 
polymer detection kit (Vector Labs, Burlingame, CA) followed by the Vector blue alkaline phosphatase substrate 
kit (Vector Labs, Burlingame, CA). After rinsing, slides were coverslipped using aqueous mounting medium (Dako, 
Carpinteria, CA). 
Immunofluorescent (IF) Labeling: Double and triple IF labeling was performed in swine tissue to 1. Compare the 
extravasation of FBG with that of another blood borne protein IgG in a section of tissue at the level of the basal 
ganglia at the level of the head of caudate nucleus in all cases and; 2. Determine the cell types associated with the 
uptake of FBG / IgG in all sections where observed on single labeling IHC.  
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Following deparaffinization and rehydration, antigen retrieval and blocking was performed as above. 
Primary antibodies were applied serially for 20 hours (4oC) and were specific for FBG (Abcam, Cambridge, MA, 
1:3K) glial fibrillary acidic protein (GFAP) (Millipore, Billerica, MA; 1:8K) ionized calcium-binding adaptor 
molecule 1 (IBA-1) and, microtubule-associated protein 2 (MAP2) (Abcam, Cambridge, MA; 1:2K). After rising, 
the corresponding Alexa Fluor (Invitrogen, Carlsbad, CA) secondary antibody was applied at 1:500 in a 2% species-
specific blocking solution for 2 hours at room temperature. For identification of IgG, a goat anti-swine IgG 
conjugated with Alexa 488 (Jackson Immunoresearch, PA; 1:20) was applied. Serial sections of positive control 
tissue (contused tissue) were subjected to the entire procedure with omission of subsets of primary antibodies to 
control for non-specific immunofluorescence. Negative controls included individual omission of primary antibodies 
to control for non-specific binding. Following rinsing, all double fluorescent-immunolabeled sections were 
coverslipped using an aqueous mounting medium (Dako, Carpinteria, CA) and visualized using a Nikon A1RSi 
Laser Scanning Confocal (Nikon, Tokyo, Japan). High resolution confocal scanning was performed at 0.5μm 
increments through the full depth of the tissue sections and image reconstruction achieved using Nikon Elements 
AR. 
 
Analysis and Quantification of Immunohistochemical Findings 
All neuropathological assessment and quantification was performed blinded to the injury status of animals 
by 2 independent examiners and inter-rater reliability was determined. Routine H&E staining was performed on 
serial sections for all brain regions examined (see below).  
Extent and Distribution of FBG Extravasation: All tissue examinations were performed on 8μm whole-brain 
coronal paraffin sections at 5 brain levels including: 1. the frontal cortex at 5mm from the frontal pole, including 
prefrontal cortex; 2. the basal ganglia at the level of the head of caudate nucleus; 3. the anterior hippocampus; 4. 
the posterior hippocampus at the level of the posterior commissure; and 5. the medulla. Levels were selected to 
incorporate a wide sampling spanning the rostrocaudal extent of the entire brain.  
For each animal, FBG labelled whole-brain sections from each of these 5 levels (see Fig 2a. for examples of brain 
levels examined) were subjected to high resolution scanning at 20X magnification using the Aperio ScanScope and 
viewed using associated Aperio ImageScope software (Leica Biosystems, Wetzlar, Germany). These digital images 
were reviewed by 2 independent observers (VJ and MW) each of whom manually outlined all regions of 
extravasated FBG to generate detailed maps of BBB disruption (Fig 2). This was achieved using the annotation tool 
on the Aperio ImageScope software. These subsequent outlines then permitted the quantification of the percentage 
area of FBG immunoreactivity for each hemisphere (across all 5 brain levels) per animal. 
Quantifying Regional Overlap Between FBG Extravasation and Axonal Pathology in Swine: The pattern and 
distribution of axonal pathology as identified by APP immunohistochemistry has previously been characterized in 
the non-impact rotational acceleration injury swine model of mild TBI used in this study [44]. 
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In order to determine the potential relationship between axonal pathology and BBB disruption, tissue dual-labelled 
for APP (axonal pathology) and FBG were examined. Animals with survival of 48-72h post-TBI were selected to 
encompass the maximal extent of axonal pathology, which is identifiable due to the abnormal accumulation of APP 
secondary to a failure of axonal transport. 
Dual-labelled coronal sections for all cases at the level of the basal ganglia at the level of the head of caudate nucleus 
(Fig 3a-b.) were selected and, as above, underwent high-resolution digital scanning at 20X magnification using the 
Aperio ScanScope and viewed using associated Aperio ImageScope software (Leica Biosystems, Wetzlar, 
Germany).   
The entire region of white matter above the level of the corpus callosum for each animal/section in both hemispheres 
was selected for examination and has previously been shown to be a region where axonal pathology is 
stereotypically observed [44]. Within this region, injured axons were identified and defined as those that were APP 
positive axonal profiles with an injured morphology including 1. Terminal axonal swellings or axonal bulbs, 
formerly known as retraction balls, and 2. axons with a beaded or fusiform morphology representing multiple points 
of apparent transport interruption as has been historically described [27, 28, 42, 43, 77, 88]. Upon identification, 
injured axons were tagged using the annotation tool in the Aperio ImageScope software. In order to determine the 
percentage of axons regionally associated with BBB disruptions, all axons were reviewed and designated as either 
1. Existing in a region of white matter with associated FBG extravasation or 2. Existing in a regions where FBG 
immunoreactivity was absent.  
Human Tissue Neuropathological Analyses: For human tissue studies, the extent of FBG extravasation was 
classified using standard semi-quantitative assessments and designated in a blinded fashion as: 0=absent, 1=minimal 
, 2=moderate, or 3=extensive pathology based on the frequency and intensity of immunoreactivity as previously 
described [34]. Score 3 (extensive) represents sections with > 50% of the section being FBG immunoreactive. 
Representative examples are shown in Supplementary Figure 2. This scoring was representative of the entire hemi-
coronal section of the parasagittal cortex at the level of the mid-thalamus to include the cingulate gyrus and corpus 
callosum.  The presence or absence of axonal pathology was noted. 
 
Statistical Analyses 
Statistical analyses for IHC quantification were performed using GraphPad Prism statistical software (GraphPad 
Software Inc. La Jolla, CA). Differences in the mean of the percentage area of FBG immunoreactivity were assessed 
using the two-sample t-test for all comparisons. Differences were considered significant if p<0.05.  
The Intraclass Correlation Coefficient (ICC) was used to determine inter-rater reliability of quantitative 
measurements of IHC findings using IBM SPSS Statistics (IBM Corporation, Armonk, NY). 
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RESULTS 
Isolated Head Rotational Acceleration Results in a Clinical Presentation Consistent with Concussion  
Following the rotational acceleration model of concussion and subsequent withdrawal of isoflurane, all 
animals mobilized rapidly, were fully conscious and alert, mental status was unaltered and normal feeding and 
drinking behavior resumed within 1-2 hours. Consistent with the clinical presentation of mild TBI, no animals 
displayed evidence of focal neurological deficit.  In all animals, neurological examination was normal and animals 
displayed normal posture, tone, gait, power, sensation, proprioception and cranial nerve examination where possible 
to examine.  
Neuropathological characterization of trauma-associated pathologies was performed following survival of 
6 hours (n=3), 48 hours (n=2) and 72 hours (n=4) post-injury and compared with shams (n=3). As previously 
reported [44], brains were normal on gross examination and indistinguishable from shams at all time points post-
injury. Consistent with clinical concussion, there was no evidence of any focal pathology, including hemorrhage. 
The brain hemispheres were symmetrical with no evidence of swelling or raised intracranial pressure (ICP). H&E 
staining confirmed an absence of any focal hemorrhagic or ischemic foci in any animals.  
 IHC specific for APP revealed swollen and morphologically altered axons consistent with transport-
interruption secondary to axonal cytoskeletal damage and indistinguishable from that observed in human DAI [1-
3, 27, 28, 42, 77].  DAI was observed in injured animals in all brain levels examined in a stereotyped multifocal 
distribution consistent with biomechanical forces as previously described in detail [44] and discussed below.  
 
Experimental Concussion Results in Acute BBB Disruption  
Multifocal FBG extravasation into the brain parenchyma was observed at 6-72 hours following a single rapid 
rotation in swine as perivascular FBG immunoreactivity in both white and gray matter in injured animals, but was 
observed minimally in shams (Fig. 1a-i). Further, detailed mapping of FBG extravasation in multiple whole-brain 
coronal sections revealed BBB leakage in a stereotyped, multifocal distribution consistent with a biomechanical 
etiology.  Specifically, structural interfaces within the brain were preferentially affected, with evidence of BBB 
disruption typically observed at gray-white interfaces, in periventricular regions (Figs. 1d-f, 2c,e) and at subpial 
zones within the cortex, often towards the dorsal surface anteriorly (Figs. Ih, 2c). Occasionally, inflection points in 
the brain architecture were also affected, including cortical sulci and the lateral aspect of the parahippocamal cortex 
where it meets the inferior temporal gyrus (Fig. 1f), further supporting a biomechanical etiology. In all cases, the 
hippocampus was affected bilaterally, with prominent FBG extravasation at the interface between the 
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hilus/molecular layer and the dentate gyrus and the vessels of the hippocampal fissure (Fig. 1g). Finally, FBG 
extravasation was observed in the thalamus at all time points (Fig. 2d). 
Quantification of the mean percentage area of FBG immunoreactivity in each hemisphere across 5 coronal 
sections was minimal in sham animals [left hemisphere: 0.18 +/- 0.01%; right hemisphere: 0.29 +/- 0.05%]. In 
comparison with sham, the mean percentage area of FBG immunoreactivity was increased in both hemispheres at 
6 hours (left hemisphere: 4.39 +/-2.30% (p=0.03), right hemisphere 3.87 +/- 1.88% (p=0.03)), and at 48 hours post-
concussion (left hemisphere: 1.16 +/- 0.46% (p=0.02), right hemisphere 1.31 +/- 0.05% (p=0.0002)). By 72 hours 
post-concussion, FBG immunoreactivity remained increased versus shams in the left hemisphere (2.30 +/- 1.32% 
(p=0.04)), with a trend to increased staining in the right hemisphere (2.50 +/- 2.27% (p=0.16)) (Fig. 1i). No 
difference in the extent of FBG immunoreactivity was observed between TBI groups at 6, 48 and 72 hours survival 
(p>0.05). Inter-rater reliability between observers was excellent with an ICC of 0.98. 
Notably, while the extent of FBG immunoreactivity did not differ between hemispheres (p>0.05), a 
stereotyped hemispheric asymmetry was observed at all three time points and was highly consistent among animals. 
Specifically, in rostral brain regions (Fig 2a,c), the left hemisphere (leading hemisphere during coronal rotation) 
displayed an increased density of extravasated FBG closer to the midline, including extensive leakage at the 
dorsolateral aspect of the lateral ventricle. This was in contrast to the right (non-leading) hemisphere, where more 
extensive extravasation was observed closer to the brain surface, including the digitate white matter and gray matter 
of the insular cortex and primary somatosensory cortex (Fig 2c).  
Immunoglobulin (IgG) IHC revealed perivascular extravasation consistent in both extent and distribution 
with that of FBG in swine (Fig S1). Additional double immunofluorescent labeling in a subset of sections confirmed 
co-localization of FBG and IgG, consistent with evidence of BBB disruption leading to global leakage of large, 
blood-borne proteins, versus being a FBG specific phenomenon (Fig S1). 
 
Regional Overlap of BBB Disruption and Axonal Pathology Following Experimental Concussion 
The spatial relationship between axonal pathology and BBB disruption in swine was revealed by examining 
whole-brain sections at 48-72h post-concussion at the level of the head of caudate nucleus (Level b; Fig. 3) labeled 
with both APP and FBG (multiple immunoenzymatic labeling) and compared to sham animals.  
Distinct axonal profiles with an injured morphology, including terminal swellings, beading and intact 
fusiform profiles were present in a stereotypical, multifocal distribution affecting the subcortical and periventricular 
white matter and midline structures of all injured animals, consistent with previous reports [44] (Fig. 3b). Notably, 
mapping of APP positive injured axons revealed overlap between regions of high-density axonal pathology and 
extensive FBG extravasation in white matter (Fig. 3a,b). However, although frequent, this overlap between APP 
positive axonal profiles and regions of FBG extravasation in white matter was not absolute (Fig. 3c,e-k). 
Specifically, though 62.8% (SD 1.8%) and 60.6% (SD 9.3%) of APP positive axons at 48h and 72h respectively 
fell within a region of co-incident FBG extravasation, the remaining axons did not (Fig. 3c). There was no difference 
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between time points (p=0.8). FBG extravasation was also frequently observed in the absence of any axonal 
pathology in both white and gray matter (Fig. 3g,k). 
 
Cellular Uptake of FBG Occurs Acutely Following Experimental Concussion 
Single labeling IHC revealed that, following concussion in swine, in addition to parenchymal FBG 
immunoreactivity, staining was also present in cellular structures within regions of high extravasation (Fig. 4). 
Morphologically, these cells appeared consistent with astrocytes and neurons, confirmed in subsequent double and 
triple immunohistochemical labeling with GFAP (Fig. 4f-i) and MAP2 (Fig. 4j,k). In contrast, only very occasional 
microglia (IBA-1 positive) were observed co-labeled with FBG, typically closely adjacent to the vessel (Fig. 4h-i). 
High resolution confocal microscopy demonstrated this FBG immunoreactivity was within neurons and astrocytes, 
rather than confined to the cell surface, indicating internalization of the protein. All studies were repeated with IgG, 
which showed a similar pattern of neuronal and astrocytic uptake (Fig S1). 
 
APP and FBG IHC Following Human Severe TBI: Comparisons with Experimental Concussion 
Following severe human TBI, APP IHC revealed axonal pathology in all TBI cases in a pattern and 
distribution consistent with DAI, with axonal profiles observed individually scattered or in small clusters, 
indistinguishable to that observed following concussion in swine [42, 43]. However, in contrast with the concussion 
model, other cases displayed additional superimposed, widespread waves of axonal APP immunoreactivity in 
keeping with axonal pathology as a result of the vascular complications of raised intracranial pressure [23, 25, 32, 
35, 42, 69]. This compared to human controls where just 1 of 7 cases displayed axonal pathology in a pattern and 
distribution in keeping with hypoxic/ischemic injury, likely indicative of an agonal event near the time of death [23, 
25, 32, 35, 42, 69].  
Moderate or extensive FBG immunostaining was observed in all but one TBI case, consistent with 
previous reports (Fig. 5) [34, 52]. This compared to controls in which there was less extensive FBG 
immunoreactivity, with just 1 case showing extensive, 1 moderate and 5 minimal extravasation (Fig. 5a), again in 
keeping with previous descriptions [34, 52]. Despite the more widespread and extensive FBG immunoreactivity in 
human severe TBI, consistent with observations in swine studies, there was increased FBG immunoreactivity 
adjacent to subpial vessels in the superficial layers of the cortex (Fig. 5c,d), as well as at the interface between 
cortical gray and underlying white matter (Fig 5e). 
Furthermore, both neuronal and glial uptake of FBG was also observed in TBI and control cases (Fig. 5e-
g), typically in regions with high parenchymal FBG extravasation. The extent of this cellular uptake was frequently 
extensive and widespread in human TBI cases, with immunoreactive astrocytes often present at the cortical surface 
(Fig 5g). 
 
 
Page 12 of 24 
 
 
DISCUSSION 
Using a swine model of concussion delivering pure head rotational acceleration and based on the kinematics 
of human concussion, we found evidence of mutlifocal BBB disruption shortly after injury. Extravasation of serum 
proteins was identified in a distribution that coincided with brain regions previously predicted to undergo greatest 
tissue deformation during injury.  While this included overlap with areas of axonal pathology in the white matter, 
BBB disruption was also found independent of axonal injury throughout the gray matter. Notably, extravasated 
serum proteins were observed within astrocytes and neurons in proximity to regions of BBB disruption shortly after 
injury, suggesting rapid uptake by these cells. These data indicate that acute dysfunction of the neurovascular unit 
may be a common pathological feature of concussion. 
While a wide range of pathologies have been characterized in human tissue studies from patients exposed 
to moderate or severe TBI [30] , the rarity of post-mortem examination following concussion has meant that current 
understanding of the pathophysiology of the injury is based largely on indirect and non-invasive studies in vivo.    
Moreover, although there are multiple rodent models of ‘mild’ TBI, there is debate regarding their fidelity to 
replicate the biomechanics and pathophysiology of human concussion.  In particular, the relatively large and 
gyrencephalic human brain endures substantial mass effects during head rotation associated with concussion, 
reflected in high strains as it is dynamically deformed. Therefore, through extensive characterization, we established 
a scaling approach to create similar mechanical loading of brain tissue between human TBI and the swine model.  
The parameters are based on Holbourn's Scaling Equation [63], where the interaction of brain mass with the level 
of head rotational acceleration is taken into account [19, 39].   Specifically, for a swine brain of 90-100g, the 
rotational acceleration forces must be increased eight-fold or more to create the same tissue deformation that a 
human brain undergoes during concussion [41, 43]. This model recapitulates many aspects of the acute clinical 
presentation of mTBI, including loss of consciousness dependent on the angle of head rotation, as well as DAI in 
the absence of overt neuropathologies.  However, there are anatomic differences between humans and swine, 
including skull architecture, that may affect the distribution of subtle neuropathologies and potentially outcome.  In 
addition, the strain of swine used does not have nearly as prominent a falx cerebri as do humans.  Since this structure 
may serve as a physical barrier during brain deformation, axonal pathology is much more prominent in midline 
structures in human TBI compared with the swine model.   
Consistent with previous studies [44], here we identified DAI following a single rotational event in swine 
in a pattern and distribution consistent with mechanical deformation, and in the absence of any hemorrhage, brain 
swelling or ischemia. These findings support emerging clinical, neuroimaging and blood biomarker data indicating 
that DAI is a key pathological substrate of concussion in humans due to mechanical vulnerability of white matter 
axons [12-14, 21, 43, 55, 59, 62, 80, 94, 95].  Nonetheless, these findings do not preclude the possibility that other 
brain structures also suffer mechanical damage within and beyond white matter.  
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Using this swine model, our current data also demonstrate that the brain vasculature is vulnerable to damage 
as a consequence of the mechanical forces of concussion.  While the specific ultrastructural nature of this 
mechanical damage to vessels remains to be determined, the resulting abrupt disruption of BBB integrity is clearly 
evidenced by multifocal pathological extravasation of large serum proteins, FBG and IgG. Of note, FBG 
immunoreactivity was observed at all time points post-injury and was most marked with a survival duration of 6 
hours. Interestingly, a biphasic course of BBB dysfunction has previously been described in the acute phase 
following models of severe TBI in rodents [9, 10].  While our data trends towards a relative decrease in FBG 
immunoreactivity at 48 hours versus 72 hours, a greater number of animals would be required to determine the time 
course of acute BBB opening. In addition, as the presence of serum proteins in brain parenchyma is determined 
both by their rate of extravasation and clearance, this is unlikely to be a precise measure of BBB opening at any 
given time-point. Future studies utilizing the terminal intravascular administration of exogenous labels e.g. Evans 
blue, will be important to accurately determine the acute temporal time course of BBB leakage in this model. 
The duration of BBB permeability in the swine model beyond the acute phase will also be important to 
explore. Indeed, considering that FBG extravasation has been observed in post-mortem human brain months and 
even years after a single moderate-severe TBI [34], a milder form of persisting BBB may also occur in some cases 
of concussion.  While the resulting downstream pathological effects of BBB dysfunction remain to be determined 
in single concussion, BBB permeability along with perivascular neuropathologies including neurofibrillary and glial 
tauopathy, have been reported in individuals with CTE following exposure to repetitive concussion [24, 56, 83].  
In the present study, FBG and IgG immunoreactivity was observed in a stereotypical, multifocal 
distribution, typically surrounding vessels of variable size. Extravasated serum proteins were frequently present 
surrounding vessels at anatomical boundaries with juxtaposing material properties, including the gray-white 
interface, subpial cortex, and adjacent to the dentate gyrus and lateral ventricles. Moreover, while there was no 
difference in the overall extent of BBB leakage between hemispheres, stereotyped hemispheric differences in the 
distribution of extravasated serum proteins suggests BBB disruption occurs in a distribution consistent with a 
mechanical etiology. 
To determine the clinical relevance of the findings in the swine concussion model, parallel examinations 
were performed on post-mortem tissue following human severe TBI.  As expected, due to the differences in injury 
severity, far more extensive and widespread FBG extravasation was found in the human TBI cases than was 
observed in swine concussion. Nonetheless, there were notably similarities in the pattern of BBB disruption between 
the two species.  As found in swine concussion, a multifocal distribution of FBG extravasation was apparent, with 
subpial vessels frequently affected and occasional focal disruptions at the gray-white boundary were also observed 
in the human cases.  As with the findings in swine, the location of these disruptions suggests a mechanical origin 
with a predominance at anatomic boundaries.  Unlike the swine concussion model, however, there were additional 
changes typical of severe TBI in humans, including evolving hemorrhagic lesions, ischemic change and brain 
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swelling.  Moreover, human control brains also displayed some degree of serum protein extravasation likely induced 
by protracted agonal or prolonged ischemic events around the time of death.  
Following concussion in swine, within the white matter, there was considerable gross regional overlap of 
abnormal FBG immunoreactivity and axonal profiles accumulating APP.  Specifically, approximately 60% of axons 
with an injured morphology were observed in regions with coincident FBG extravasation. This suggests that the 
overlapping pattern of both pathologies in white matter might reflect regions of higher mechanical injury during 
rotational acceleration.   Since physical and computational models of swine TBI have shown both gray and white 
matter undergo a heterogeneous pattern of high stresses and strains, future studies could examine whether BBB 
disruption following in vivo injury could be used as a pathological marker for loading distribution throughout the 
entire brain. 
The overlap of different neuropathologies agrees with biomechanics literature showing the mechanical 
threshold for compromise of the BBB overlaps with thresholds for axonal injury [8, 79]. In general, the direction of 
impact, acceleration profile, and relative size and shape of the brain all contribute to areas of maximum deformation 
within the brain during ‘real world’ impacts that cause concussion [22].  Thus, identification of BBB disruption 
may serve as a type of “injury strain gauge”, showing regions that endured the highest deformations in both the 
gray and white matter.  
With regards to white matter, at the local scale, tissue deformations can parallel the trajectory of axons 
within a region, maximally stretching these axons. In this scenario, axonal injury may appear in the absence of BBB 
compromise. In comparison, if tissue stretch appears perpendicular to primary axonal pathways, axons are not 
stretched significantly and BBB compromise can occur prior to any evidence of axonal damage. Finally, when the 
local tissue deformation is enough to exceed both the local tolerance of the microvasculature and the tolerance of 
axons aligned with the deformation field, one would see the co-localization of BBB and axonal injury. We observed 
each of these three injury phenotypes in our swine concussion model. The process of accounting for the 
microanatomy of the brain in predicting injury risk is now appearing in computational models of the brain to predict 
concussion injury risk [29, 40, 64], and our observations reinforce the need to accurately align the biomechanical 
features of injury with the anatomy. In the future, we expect these computational efforts will evolve to include 
estimates of damage to the brain network structure [47], which would significantly enhance our ability to connect 
the initial injury to the consequences of the injury over time. 
Intriguingly, in addition to leaking into the brain parenchyma, serum proteins were also found to be taken 
up by local cells.  Perivascular clusters of both neurons and astrocytes immunoreactive for FBG and IgG were 
observed following both concussion in swine and severe TBI in humans. Similar cellular uptake of serum proteins, 
including FBG, has been described in other disorders where BBB dysfunction features, including cerebrovascular 
disease [15, 90], epilepsy [53],  multiple sclerosis [7, 45, 48], cerebral malaria [16], acquired immunodeficiency 
syndrome [65], HIV encephalitis [20] and Alzheimer’s disease [72, 90, 92]. Surprisingly, there was minimal uptake 
of serum proteins by microglia when compared with astrocytes and neurons, which may reflect cell-specific uptake 
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for clearance of serum proteins after TBI. Notably, astrocytes have previously been demonstrated to selectively 
clear FBG in vitro [38]. Since neurons staining for FBG following concussion appeared morphologically normal at 
the time points examined in the present study, further temporal studies would be required to examine if this uptake 
has pathological consequences.  
The specific mechanisms by which extravasation of serum proteins in TBI are potentially neurotoxic remain 
to be explored. However, in addition to its role in hemostasis, FBG is increasingly recognized for its additional and 
diverse contribution to CNS pathology via mediation of inflammatory processes [4, 5], astrocyte activation [75] 
autoimmunity and demyelination [6, 73]. Moreover, FBG has been demonstrated to inhibit CNS neurite outgrowth 
in vitro and in vivo [74] and thus may be a potential barrier to axonal recovery in concussion, where white matter 
injury is a primary pathology [12-14, 21, 55, 59, 62, 80, 94, 95]. Interestingly, exposure of the brain to serum 
proteins has been speculated as a potential mechanism driving age-related tau astrogliopathy (ARTAG), a 
pathological accumulation of abnormally phosphorylated tau in astrocytes that occurs in a subpial, subependymal 
and perivascular distribution [46]. However, the presence of ARTAG following TBI has yet to be characterized. 
In addition to the exploration of potential downstream neuropathological consequences of serum protein 
extravasation, it will be critical to examine the pathophysiological mechanisms that drive BBB dysfunction in 
concussion. This may include the immediate mechanical failure of the barrier, potentially caused by direct 
disruption of endothelial tight-junctions. In contrast, downstream pathophysiological alterations to the BBB, 
including altered transcellular transport, will also be important to examine since it has been demonstrated following 
an impact model of TBI in cats [67]. Interestingly, the matrix metalloproteases (MMPs), including MMP-9 in 
particular, are increasingly recognized as mediators of BBB permeability following TBI and their role in concussion 
should also be determined [50, 60, 78, 96]. 
Overall, we demonstrate that acute BBB disruption is a primary consequence of head rotational acceleration 
in a swine model of concussion. This observation could help direct non-invasive diagnosis of concussion, such as 
advanced neuroimaging techniques to identify the extent and distribution of BBB leakage [91]. In addition, 
characterizing the nature and time course of BBB permeability may have direct relevance for the development of 
serum biomarkers for concussion [30, 44, 81], and for the timing of delivery of potential pharmacological 
interventions. 
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Table 1. Demographic and Clinical Data 
 TBI Cases (n=12) Controls (n=7) 
Age  Mean 
(Range) 
44 years 
(18-58 years) 
32 years 
(16-60 years) 
Males  7 (58%) 4 (57%)  
Mean Survival Time 
(Range)  
 27h (6-72 hours) Not Applicable 
Mean Post-Mortem Delay 
(Range) 
56 hours 
(3-120 hours) 
56 hours 
(12-120 hours) 
Cause 
of 
Injury 
Assault 1 (8.3%) Not Applicable  
Fall 7 (58.3%) 
Motor vehicle 
collision 
4 (33.3%) 
Cause of Death 
TBI 12 (100%) 0(0%) 
Acute Cardiovascular Death  3 (43%) 
Inhalation Gastric Contents 1 (14%) 
Acute Death associated 
with amphetamine  
1 (14%) 
Bronchopneumonia 
secondary to malignancy 
1 (14%) 
Septicemia 1 (14%) 
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Figure Legend 
Fig 1 Experimental Concussion Induces Multifocal BBB Leakage.  (a) An absence of FBG immunoreactivity 
in the subcortical white matter in a sham animal. Immunoreactivity specific for FBG; (b) surrounding a vessel in 
the parenchyma of the thalamus 6 hours following a single experimental concussion; (c) in the subcortical white 
matter at the level of the head of the caudate nucleus 48 hours following experimental concussion; (d) at the tip of 
the lateral ventricle preferentially in left hemisphere (leading hemisphere in rotation) 6 hours following 
experimental concussion; (e) at the ventricular interface of the corpus callosum 72 hours following experimental 
concussion; (f) in the periventricular white matter and depth of the sulci at the lateral aspect of the parahippocamal 
cortex where it meets the inferior temporal gyrus, 6 hours post- experimental concussion; (g) adjacent to the dentate 
gyrus and vessels of the hippocampal fissure 6 hours following experimental concussion; and (h) at the cortical 
surface in the frontal lobe 72 hours post- experimental concussion. (i) Graph showing the percentage area of FBG 
immunoreactivity for the whole coronal brain hemispheres for each animal in all 5 levels combined.  Scale bars: 
(a,c) 200μm, (b,e) 300μm, (d) 3mm, (f) 2mm, (g) 400μm, (h) 500μm  
 
Fig 2 BBB Leakage Occurs in a Biomechanical Distribution after Experimental Concussion. (a) MRI image 
with vertical dotted lines indicating the levels of brain examined in the coronal plane. (b-f) Whole brain coronal 
maps showing FBG extavasation annotated manually following high resolution digital scanning in each of the 5 
levels denoted in (a). Scale bars: 5mm 
 
Fig 3 BBB Leakage Has Limited Regional Overlap with Axonal Pathology after Experimental Concussion.  
(a) Whole section map of annotated FBG immunoreactivity at 48 hours post- experimental concussion. (b) Adjacent 
section to (a) showing APP positive axonal pathology in a distribution that overlaps with FBG leakage in the white 
matter. (c) Graph showing the percentage of APP positive profiles identified in regions where coincident FBG 
extravasation is observed via multiple chromagen staining at 48 hours and 72 hours post- experimental concussion. 
(d) FBG (blue) confined to the vascular compartment in a sham with no extravasation into the brain parenchyma. 
No axonal pathology is observed (brown). (e-f, h) Regions of extensive FBG extravasation (blue) and axonal 
pathology (brown) in the (e) deep cortical white matter 48 hours following experimental concussion, and (f) gray-
white interface of the frontal cortex at 72 hours post- experimental concussion and (h) the periventricular region of 
the leading hemisphere at 48 hours post- experimental concussion. (i) Scattered axonal pathology both within and 
beyond regions of extravasated FBG in the white matter at 48 hours post- experimental concussion. (j) APP 
immunoreactive axonal pathology in the perivascular region without FBG extravasation. (g, k) Overt FBG 
extravasation without axonal pathology in the gray-white interface (g) and deep white matter (k) at 48 hours post-
concussion.  Scale bars: (a-b) 6mm, (d-k) 100μm 
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Fig 4 Astrocytes and Neurons Internalize Blood-Borne Proteins after Experimental Concussion. (a) FBG 
immunoreactive cells with a glial morphology at the depth of the sulcus within the inferior temporal gyrus 48 hours 
post- experimental concussion. (b) Higher magnification of box in (a). (c) Cells with neuronal morphology and 
immunoreactive for FBG in the caudate nucleus 72 hours post- experimental concussion. (d) Normal vessels 
without FBG (red) extravasation. FBG is confined to the vessel lumen without co-localization with astrocytes 
(GFAP; green) or microglia (IBA-1; purple). (e) Higher magnification of box in (d). (f) Vessels in premotor cortex 
showing marked FBG (red) extravasation 72 hours post- experimental concussion. Co-localization with astrocytes 
(GFAP; green) is observed. Only minimal co-localization with microglia (IBA-1; purple) was observed in cells 
immediately adjacent to the vessel. (g) Higher magnification of region in (f). (h) Penetrating surface vessels of 
parietal cortex showing marked FBG (red) extravasation 72 hours post- experimental concussion with co-
localization with astrocytes (GFAP; green). (i) Higher magnification of box in (h). (j) Cells in the frontal cortex 
with neuronal morphology that are negative for IBA-1 (purple) and GFAP (green), yet co-localize with FBG (red).  
(k) Neuronal cell-type was confirmed with evidence of co-localization of MAP-2 (green) cells and FBG (red). Scale 
bars: (a,c) 100μm, (b, e) 25μm, (d, f-k) 50μm 
 
Fig 5  FBG Extravasation after Acute Severe TBI in Humans. (a) An absence of FBG immunoreactivity out 
with the vascular compartment in a 20 year old male control that died following a sudden cardiac event secondary 
to hypertrophic cardiomyopathy. (b) Marked FBG extravasation in a perivascular distribution at the gray-white 
interface in the superior frontal gyri in a 20 year old male 48 hours following TBI caused by assault. (c) FBG 
extravasation and associated glial uptake at the depth of sulci in a 58 year old male that died 6 hours following TBI 
caused by assault. (d) A penetrating vessel at the cortical surface of the cingulate gyrus surrounded by extravasated 
FBG (same case as b). (e) Extensive neuronal uptake of FBG in the superior frontal gyrus in a 58 year old male 6 
hours after TBI caused by a fall. (f) High magnification of a neuron immunoreactive for FBG in an 18 year old male 
10 hours after a fall. (g) An astrocyte immunoreactive for FBG with process extending towards a vessel at the 
surface of the cingulate cortex in a 56 year old female 24 hours following TBI caused by a road traffic accident. 
Scale bars (a-e,g) 100μm, (f) 50μm 
Supplementary Figures 
Fig S1 IgG Extravasation and Cellular Uptake Following Experimental Concussion. IgG extravasation was 
observed in a similar pattern and distribution to FBG shown at (a) the inferior aspect of the lateral ventricle and (b) 
a penetrating vessel at the cortical surface. (c) Cellular uptake of IgG was observed including cells with the 
morphological appearance of glia at the depth of a cortical sulcus and (d) cortical neurons. (e) Astrocytic 
(arrowhead) immunoreactivity for IgG was confirmed using triple labeling immunofluorescence with markers IgG 
(green), IBA-1 (red) and GFAP (purple). Note a cell with the morphological appearance of a neuron with no co-
localization with glial marker is also shown (arrow). (f) Neuronal uptake was further confirmed with markers IgG 
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(green) and MAP-2 (red) demonstrating co-localization.  (g-i) Similar patterns of IgG (green) and FBG (red) 
extravasation were observed in double immunofluorescent labeling studies. Scale bars: (a-d) 25 μm, (e-i) 20μm 
 
Fig S2 Representative Examples of Semiquantitative Scoring for FBG Extravasation in Human Tissue. 
Representative examples (a) Minimal (score 1), (b) Moderate (score 2) and (c) Extensive (score 3) FBG 
extravasation in human postmortem material including the entire hemi-coronal section of the parasagittal cortex at 
the level of the mid-thalamus to include the cingulate gyrus and corpus callosum. Scale bars (a-c) 1mm 
 
 
 
  
